Health Care & Life Sciences » Pharmaceuticals | Ohr Pharmaceutical Inc.

Ohr Pharmaceutical Inc. | Balance Sheet

Fiscal year is October-September. All values USD Thousands.
2013
2014
2015
2016
2017
2018
Cash & Short Term Investments
5,122.90
13,220.50
28,697.30
12,546.90
12,801.10
3,750.40
Other Current Assets
45.40
133.50
338.70
738.10
223.30
248
Total Current Assets
5,168.20
13,354.00
29,036.00
13,285.00
13,024.40
3,998.40
Net Property, Plant & Equipment
29.80
104.40
248.80
198.60
63.80
15.80
Total Investments and Advances
-
15.40
12.20
-
-
-
Intangible Assets
545.90
18,551.30
17,073.80
15,949.10
14,828.50
7,611.90
Other Assets
-
-
-
12.20
12.20
-
Total Assets
5,743.90
32,025.10
46,370.80
29,445.00
27,928.90
11,626.10
ST Debt & Current Portion LT Debt
14.10
43.90
48.10
87.80
106.40
Accounts Payable
-
-
-
-
4,827.50
Other Current Liabilities
465.70
5,229.20
3,832.00
4,394.10
0.00
Total Current Liabilities
479.70
5,273.10
3,880.00
4,481.90
4,933.90
Other Liabilities
-
-
-
-
150.00
Total Liabilities
479.70
5,273.10
3,880.00
4,481.90
5,083.90
Common Equity (Total)
5,264.10
26,752.00
42,490.80
24,963.10
22,845.00
Total Shareholders' Equity
5,264.10
26,752.00
42,490.80
24,963.10
22,845.00
Total Equity
5,264.10
26,752.00
42,490.80
24,963.10
22,845.00
Liabilities & Shareholders' Equity
5,743.90
32,025.10
46,370.80
29,445.00
27,928.90
Preferred Stock (Carrying Value)
0.10
-
-
-
-

About Ohr Pharmaceutical

View Profile
Address
800 Third Avenue
New York New York 10022
United States
Employees -
Website http://www.ohrpharmaceutical.com
Updated 07/08/2019
Ohr Pharmaceutical, Inc. is a clinical stage company which develops novel therapies for ophthalmic diseases. Its product provides a non-invasive therapy to improve vision outcomes. The company was founded by Irach B.